Instrument Inactif

Communiqués Aratana Therapeutics Inc

Actions

US03874P1012

Produits pharmaceutiques

Communiqués

16/07/19	Aratana Therapeutics' : Stockholders Adopt Merger Agreement with Elanco Animal Health	PR
11/06/19	Aratana Therapeutics : Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial	PR
07/06/19	Aratana Therapeutics : Reports Voting Results from 2019 Annual Meeting of Stockholders	PR
08/05/19	Aratana Therapeutics : Reports First Quarter 2019 Financial Results	PR
07/05/19	Aratana Therapeutics : to Present at Stifel 2019 Dental & Veterinary Conference	PR
03/05/19	ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX	BU
22/04/19	Aratana Therapeutics : to Report First Quarter 2019 Financial Results	PR
12/03/19	Aratana Therapeutics : Reports Fourth Quarter and Full Year 2018 Financial Results	PR
13/02/19	Aratana Therapeutics : to Participate at Upcoming Investment Conferences	PR
12/02/19	Aratana Therapeutics : to Report Fourth Quarter and Full Year 2018 Financial Results	PR
04/02/19	Aratana Therapeutics : Appoints Rhonda Hellums Chief Financial Officer	PR
18/01/19	Aratana Therapeutics :' Board of Directors Appoints Craig Tooman Chief Executive Officer	PR
01/11/18	Aratana Therapeutics : Reports Third Quarter 2018 Financial Results	PR
22/10/18	Aratana Therapeutics : to Report Third Quarter 2018 Financial Results	PR
29/08/18	Aratana Therapeutics : to Present at CL King and Associates Best Ideas Conference	PR
02/08/18	Aratana Therapeutics : Reports Second Quarter 2018 Financial Results	PR
10/07/18	Aratana Therapeutics : to Report Second Quarter 2018 Financial Results	PR
01/06/18	Aratana Therapeutics : Files for FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) Label Expansion	PR
22/05/18	Aratana Therapeutics : to Participate at Jefferies 2018 Global Healthcare Conference	PR
21/05/18	Aratana Therapeutics : Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital	PR
03/05/18	Aratana Therapeutics : Reports First Quarter 2018 Financial Results	PR
12/04/18	Aratana Therapeutics : to Report First Quarter 2018 Financial Results	PR
05/04/18	Aratana Therapeutics : Confirms Receipt of Board Nominations	PR
13/03/18	Aratana Therapeutics : Reports Fourth Quarter and Full Year 2017 Financial Results	PR
02/03/18	Aratana Therapeutics : to Participate at Upcoming Investment Conferences	PR